Label: MAXIMUM OTC STRENGTH FEMININE ANTI-ITCH CREME- benzocaine, resorcinol cream

  • NDC Code(s): 83324-019-01
  • Packager: Quality Choice (CHAIN DRUG MARKETING ASSOCIATION)
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated April 11, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts Active ingredients

    Benzocaine 20%

    Resorcinol 3%

  • Purpose

    External analgesic

  • Keep out of reach of children

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

  • Use

    temporarily relieves itching

  • Warnings

    For external use only

  • When using this product

    avoid contact with the eyes

  • Stop use and ask a doctor if

    condition worsens, or if symptoms persist for more than7 days or clear up and occur again within a few days

  • Do not apply Directions

    Do not apply over large area of the body.

    adults and children 12 years and older: apply a fingertip amount (approximately 1-inch strip) to the affected area not more than 3 to 4 times daily

    children under 12 years: do not use; consult a doctor

  • Other Information

    store at 20° -25° C (68° -77° F)

  • Inactive Ingredients

    aloe vera leaf, alpha-tocopherol, butylated hydroxytoluene, carbomer, cetyl alcohol cholecalciferol, glyceryl monostearate,

    isopropyl myristate, isopropyl palmitate, isopropyl stearate, mineral oil, PEG 100 stearate, PEG 4000, phenoxy ethanol, propylene glycol, sodium hydroxide, sodium lauryl sulfate, trisodium edta, vitamin A palmitate, water

  • Questions or comments?

    1-866-326-1313

  • Quality Choice Maximum OTC Strength Feminine Anti-itch Creme

    Pack

  • INGREDIENTS AND APPEARANCE
    MAXIMUM OTC STRENGTH FEMININE ANTI-ITCH CREME 
    benzocaine, resorcinol cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83324-019
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE5.67 g  in 28 g
    RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL0.85 g  in 28 g
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    CHOLECALCIFEROL (UNII: 1C6V77QF41)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
    ISOPROPYL STEARATE (UNII: 43253ZW1MZ)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    ALPHA-TOCOPHEROL (UNII: H4N855PNZ1)  
    EDETATE TRISODIUM (UNII: 420IP921MB)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83324-019-0128.3 g in 1 TUBE; Type 0: Not a Combination Product01/01/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01701/01/2024
    Labeler - Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) (011920774)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!